Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report

Abstract Background Vaccine-induced thrombotic thrombocytopenia is associated with the coronavirus disease 2019 vaccines. It has been reported by vector-based vaccines. To the best of our knowledge, there is no report about vaccine-induced thrombotic thrombocytopenia in whole-virus vaccines. We are...

Full description

Bibliographic Details
Main Authors: Mohammad Sistanizad, Tahereh Sabaghian, Hossein Amini, Fahimeh Hadavand, Mahmood Nabavi, Mehran Kouchek, Mir Mohammad Miri, Sara Salarian, Seyedpouzhia Shojaei, Omid Moradi
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Journal of Medical Case Reports
Subjects:
Online Access:https://doi.org/10.1186/s13256-023-04086-7
_version_ 1797452492098764800
author Mohammad Sistanizad
Tahereh Sabaghian
Hossein Amini
Fahimeh Hadavand
Mahmood Nabavi
Mehran Kouchek
Mir Mohammad Miri
Sara Salarian
Seyedpouzhia Shojaei
Omid Moradi
author_facet Mohammad Sistanizad
Tahereh Sabaghian
Hossein Amini
Fahimeh Hadavand
Mahmood Nabavi
Mehran Kouchek
Mir Mohammad Miri
Sara Salarian
Seyedpouzhia Shojaei
Omid Moradi
author_sort Mohammad Sistanizad
collection DOAJ
description Abstract Background Vaccine-induced thrombotic thrombocytopenia is associated with the coronavirus disease 2019 vaccines. It has been reported by vector-based vaccines. To the best of our knowledge, there is no report about vaccine-induced thrombotic thrombocytopenia in whole-virus vaccines. We are presenting the first case of vaccine-induced thrombotic thrombocytopenia with this type of vaccine. Case presentation An 18-year-old male Caucasian patient with complaints of severe abdominal, low back, and lower extremity pain presented to the medical center. He received the first dose of the Sinopharm (HB02) vaccine against coronavirus disease 2019 10 days before hospital attendance. In the laboratory examination, decreased platelet count and increased D-dimer were observed. During hospital admission, the diagnosis of pulmonary embolism was reached. He received vaccine-induced thrombotic thrombocytopenia therapy consisting of intravenous immune globulin and direct oral anticoagulant. Platelet count increased and he was discharged after 1 month. Conclusion This case highlights the possibility of vaccine-induced thrombotic thrombocytopenia occurrence by whole-virus coronavirus disease 2019 vaccines. Compared with vector-based vaccines, this phenomenon is rare for whole-virus vaccines. More studies on this type of vaccine regarding thrombotic thrombocytopenia should be considered.
first_indexed 2024-03-09T15:09:27Z
format Article
id doaj.art-0d83d0ac54c44340a6b698594db76c86
institution Directory Open Access Journal
issn 1752-1947
language English
last_indexed 2024-03-09T15:09:27Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Journal of Medical Case Reports
spelling doaj.art-0d83d0ac54c44340a6b698594db76c862023-11-26T13:25:44ZengBMCJournal of Medical Case Reports1752-19472023-09-011711510.1186/s13256-023-04086-7Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case reportMohammad Sistanizad0Tahereh Sabaghian1Hossein Amini2Fahimeh Hadavand3Mahmood Nabavi4Mehran Kouchek5Mir Mohammad Miri6Sara Salarian7Seyedpouzhia Shojaei8Omid Moradi9Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical SciencesDivision of Nephrology, Department of Internal Medicine, Shahid Beheshti University of Medical SciencesDepartment of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical SciencesInfectious Diseases and Tropical Medicine Research Center, Imam Hossein Teaching and Medical Center, Shahid Beheshti University of Medical SciencesInfectious Diseases and Tropical Medicine Research Center, Imam Hossein Teaching and Medical Center, Shahid Beheshti University of Medical SciencesDepartment of Pulmonary and Critical Care Medicine, Imam Hossein Teaching and Educational Center, Shahid Beheshti University of Medical SciencesDepartment of Pulmonary and Critical Care Medicine, Imam Hossein Teaching and Educational Center, Shahid Beheshti University of Medical SciencesDepartment of Pulmonary and Critical Care Medicine, Imam Hossein Teaching and Educational Center, Shahid Beheshti University of Medical SciencesDepartment of Pulmonary and Critical Care Medicine, Imam Hossein Teaching and Educational Center, Shahid Beheshti University of Medical SciencesDepartment of Clinical Pharmacy, Faculty of Pharmacy, Hormozgan University of Medical SciencesAbstract Background Vaccine-induced thrombotic thrombocytopenia is associated with the coronavirus disease 2019 vaccines. It has been reported by vector-based vaccines. To the best of our knowledge, there is no report about vaccine-induced thrombotic thrombocytopenia in whole-virus vaccines. We are presenting the first case of vaccine-induced thrombotic thrombocytopenia with this type of vaccine. Case presentation An 18-year-old male Caucasian patient with complaints of severe abdominal, low back, and lower extremity pain presented to the medical center. He received the first dose of the Sinopharm (HB02) vaccine against coronavirus disease 2019 10 days before hospital attendance. In the laboratory examination, decreased platelet count and increased D-dimer were observed. During hospital admission, the diagnosis of pulmonary embolism was reached. He received vaccine-induced thrombotic thrombocytopenia therapy consisting of intravenous immune globulin and direct oral anticoagulant. Platelet count increased and he was discharged after 1 month. Conclusion This case highlights the possibility of vaccine-induced thrombotic thrombocytopenia occurrence by whole-virus coronavirus disease 2019 vaccines. Compared with vector-based vaccines, this phenomenon is rare for whole-virus vaccines. More studies on this type of vaccine regarding thrombotic thrombocytopenia should be considered.https://doi.org/10.1186/s13256-023-04086-7COVID-19VaccineThrombosisWhole-virus vaccineCase report
spellingShingle Mohammad Sistanizad
Tahereh Sabaghian
Hossein Amini
Fahimeh Hadavand
Mahmood Nabavi
Mehran Kouchek
Mir Mohammad Miri
Sara Salarian
Seyedpouzhia Shojaei
Omid Moradi
Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
Journal of Medical Case Reports
COVID-19
Vaccine
Thrombosis
Whole-virus vaccine
Case report
title Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
title_full Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
title_fullStr Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
title_full_unstemmed Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
title_short Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
title_sort sinopharm hb02 associated vaccine induced immune thrombotic thrombocytopenia a case report
topic COVID-19
Vaccine
Thrombosis
Whole-virus vaccine
Case report
url https://doi.org/10.1186/s13256-023-04086-7
work_keys_str_mv AT mohammadsistanizad sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport
AT taherehsabaghian sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport
AT hosseinamini sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport
AT fahimehhadavand sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport
AT mahmoodnabavi sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport
AT mehrankouchek sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport
AT mirmohammadmiri sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport
AT sarasalarian sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport
AT seyedpouzhiashojaei sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport
AT omidmoradi sinopharmhb02associatedvaccineinducedimmunethromboticthrombocytopeniaacasereport